IL142641A0 - Use of antifungal agents for treating scleroses - Google Patents

Use of antifungal agents for treating scleroses

Info

Publication number
IL142641A0
IL142641A0 IL14264199A IL14264199A IL142641A0 IL 142641 A0 IL142641 A0 IL 142641A0 IL 14264199 A IL14264199 A IL 14264199A IL 14264199 A IL14264199 A IL 14264199A IL 142641 A0 IL142641 A0 IL 142641A0
Authority
IL
Israel
Prior art keywords
scleroses
treating
antifungal agents
antifungal
agents
Prior art date
Application number
IL14264199A
Original Assignee
Candida Medical B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Candida Medical B V filed Critical Candida Medical B V
Publication of IL142641A0 publication Critical patent/IL142641A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL14264199A 1998-10-27 1999-10-27 Use of antifungal agents for treating scleroses IL142641A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR1998/002302 WO2000024402A1 (en) 1998-10-27 1998-10-27 Use of antifungal agents for treating scleroses
PCT/FR1999/002617 WO2000024403A1 (en) 1998-10-27 1999-10-27 Use of antifungal agents for treating scleroses

Publications (1)

Publication Number Publication Date
IL142641A0 true IL142641A0 (en) 2002-03-10

Family

ID=9523370

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14264199A IL142641A0 (en) 1998-10-27 1999-10-27 Use of antifungal agents for treating scleroses

Country Status (8)

Country Link
EP (1) EP1124560A1 (en)
JP (1) JP2002528064A (en)
CN (1) CN1328466A (en)
AU (2) AU1036999A (en)
BR (1) BR9914792A (en)
CA (1) CA2348160A1 (en)
IL (1) IL142641A0 (en)
WO (2) WO2000024402A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9915625D0 (en) * 1999-07-02 1999-09-01 Cortendo Ab Method
CN110269939A (en) * 2019-03-12 2019-09-24 武汉愔紫生物科技有限公司 A kind of drug, pharmaceutical composition, purposes and its application method for treating the protein mediated inflammation disease marker of fungus secretion
CN110343650B (en) * 2019-05-28 2020-12-29 浙江工业大学 Recombinant streptomyces tuberculatus for producing amphotericin B and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE753078A (en) * 1969-07-07 1971-01-07 Schmid Inc Julius HYPERLIPEMIA TREATMENT COMPOSITIONS
US4289757A (en) * 1978-02-28 1981-09-15 The Upjohn Company Method for treating inflammation
US5358959A (en) * 1993-02-18 1994-10-25 President And Fellows Of Harvard University Methods for treating arteriosclerosis
GB2290707A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of Amphotericin B
GB2290709A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of nystatin

Also Published As

Publication number Publication date
CA2348160A1 (en) 2000-05-04
AU1036999A (en) 2000-05-15
EP1124560A1 (en) 2001-08-22
AU6347199A (en) 2000-05-15
WO2000024403A1 (en) 2000-05-04
BR9914792A (en) 2001-11-27
JP2002528064A (en) 2002-09-03
WO2000024402A1 (en) 2000-05-04
CN1328466A (en) 2001-12-26

Similar Documents

Publication Publication Date Title
GB9820113D0 (en) Therapeutic agents
HK1022270A1 (en) Use of anti-microtubule agents for treating or preventing multiple-sclerosis
GB9816263D0 (en) Therapeutic agents
GB9806102D0 (en) Therapeutic agents
GB9808490D0 (en) Well treatment for water restriction
GB9804526D0 (en) Screening for functional antisense agents
IL142588A0 (en) Therapy for improving cognition
IL135232A (en) 21-hydroxy-6 19-oxidoprogesterone for treating excess of glucocorticoids
GB0114040D0 (en) Auxiliary surface treating arrangement for surface
EP0742849A4 (en) Surface treatment agent for zinciferous-plated steel
HK1042847A1 (en) Bone-pathobolism treating agent
HUP0200288A3 (en) Use of pde4 for treating copd
HUP0302430A3 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontience
GB2332437B (en) Metal surface treatment agent
HUP0204208A3 (en) Antipruritic agents for external use
IL142641A0 (en) Use of antifungal agents for treating scleroses
GB9718712D0 (en) Theraputic Agents
PL340430A1 (en) Combination for treating aids
GB9810092D0 (en) Therapeutic agents
PL334803A1 (en) Derivatives of imino-aza-antracyclinone for treating amyloidosis
GB9824160D0 (en) Heterocyclic compounds and their therapeutic use
GB9819484D0 (en) Therapeutic agents
IL149314A0 (en) Agent for treating hepatitis c
GB9815317D0 (en) Therapeutic agents
GB9805716D0 (en) Therapeutic agents